Collectively, these molecular mechanisms highlight the central roles of IFN-γ and TNF-α in systemic inflammation and atherogenesis, providing a biological rationale for their identification as prognostic biomarkers for systemic cardiovascular risk in patients with PAD. The gene discussed is TNF; the disease is peripheral arterial disease.